Saamia Faruqui, Fidelis C Okoli, Sonja K Olsen, David M Feldman, Harmit S Kalia, James S Park, Carmen M Stanca, Viviana Figueroa Diaz, Sarah Yuan, Nabil N Dagher, Suparna A Sarkar, Neil D Theise, Sooah Kim, Krishna Shanbhogue, Ira M Jacobson
INTRODUCTION: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 virus, is a predominantly respiratory tract infection with the capacity to affect multiple organ systems. Abnormal liver tests, mainly transaminase elevations, have been reported in hospitalized patients. We describe a syndrome of cholangiopathy in patients recovering from severe COVID-19 characterized by marked elevation in serum alkaline phosphatase (ALP) accompanied by evidence of bile duct injury on imaging...
July 1, 2021: American Journal of Gastroenterology